Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01808963 · ClinicalTrials.gov registry record

Evaluation of Respiratory Heast Loss as a Physiologic Patient Monitor for Acute Care Medicine

A clinical trial, sponsored by University of California, Davis.

Completed
Registry status
13
Enrollment target

NCT01808963: Completed study, sponsored by University of California, Davis.

NCT01808963 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01808963 has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
13 participants
Enrollment target

Study Summary

To evaluate the utility of respiratory heat loss measurements as a physiologic monitor.

Primary Outcome

Respired gas heat content

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2012-12
Est. Completion 2013-06
University of California, Davis

657 total trials

What the finished NCT01808963 record still lists

NCT01808963 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01808963 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01808963 about?

NCT01808963 is a clinical study titled "Evaluation of Respiratory Heast Loss as a Physiologic Patient Monitor for Acute Care Medicine". To evaluate the utility of respiratory heat loss measurements as a physiologic monitor.

What is the current status of trial NCT01808963?

This trial is currently completed. The enrollment target is 13 participants. The study started on 2012-12. Estimated completion is 2013-06.

Who is sponsoring clinical trial NCT01808963?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01808963, the US trial registry maintained by the National Library of Medicine. NCT01808963 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.